ArticleJournal of nanobiotechnology2026

ISL@mTOMV nanoparticles: a promising approach for VM-targeted therapy in breast cancer.

Chengxiao Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.